Back

Resveratrol attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of doxorubicin cardiomyopathy

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Basic Science: Cardiomyopathy Cardiomyopathies HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Donato Cappetta

Second University of Naples, Naples (Italy)

23 More presentations in this session

Presentation thumbnail
Endothelial leptin receptor signalling contributes to the development of cardiac hypertrophy and fibrosis following chronic pressure overload in mice
Doctor R. Gogiraju (Mainz, DE)
Abstract
Presentation thumbnail
Histologic and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy: a clinical-pathological study of 30 explanted hearts
Doctor G. Galati (Milan, IT)
Abstract Slides
Presentation thumbnail
MiR-181a mediates the effects of the CB1 inhibition on cardiac remodelling
Presentation thumbnail
Pharmacological inhibition of sphingosine 1-phosphate receptor 2 (S1pr2) ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice
Professor L. Zhang (Shanghai, CN)
Abstract
Presentation thumbnail
Association of angiotensin-converting enzyme polymorphism with phenotype of hypertrophic cardiomyopathy
Professor R. Mourilhe Rocha (Rio de Janeiro, BR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Basic Science: Cardiomyopathy

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources